Imagen de Portada

Trends in clinical characteristics, medication use, and glycemic control in insulin‐treated patients with type 1 and type 2 diabetes in Finland in 2012–2019: Nationwide real‐world evidence study

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Leo Niskanen, Minna Hannula, Kai Kysenius, Saara Kaijala, Mariann I. Lassenius, Timo T. Valle
Formato:	Artículo Open Access
Publicado:	Wiley 2024
Materias:	Journal of Diabetes
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Using automated insulin delivery to address the clinical challenges of glycemic management in people with type 1 diabetes and kidney failure on maintenance hemodialysis
por: Panagiotis Pavlou, et al.
Publicado: (2025)

Comparable glycemic outcomes with insulin glargine and insulin degludec during exercise in adolescents with type 1 diabetes using a standardized management protocol
por: Ivana Rabbone, et al.
Publicado: (2025)

Real‐world evaluation of teplizumab in type 1 diabetes: Progression to insulin requirement
por: Sahana Mahesh, et al.
Publicado: (2025)

Frequency of hypoglycaemia with basal insulin treatments in adults with type 1 diabetes treated with basal‐bolus insulin regimens in treat‐to‐target trials: A narrative review
por: David Russell‐Jones, et al.
Publicado: (2024)

Fear of hypoglycemia relates to glycemic levels during and after real‐world physical activity in adolescents with type 1 diabetes
por: Susana R. Patton, et al.
Publicado: (2024)

Insulin requirements during pregnancy in women with type 1 diabetes treated with insulin pump
por: Nimrod Dori‐Dayan, et al.
Publicado: (2024)

Associations between impaired awareness of hypoglycaemia and mental health in insulin‐treated type 2 and type 1 diabetes in the Hypo‐ METRICS study
por: Aisling McCarthy, et al.
Publicado: (2026)

Pharmacological characteristics of once‐weekly insulin icodec in Japanese individuals with type 1 diabetes
por: Takashi Eto, et al.
Publicado: (2024)

Increase in soluble RAGE following intensive insulin therapy is associated with β‐cell functional improvement and glycemic remission in newly diagnosed type 2 diabetes
por: Qimou Chen, et al.
Publicado: (2026)

The daunting task of recruiting insulin‐treated patients living with type 2 diabetes mellitus for intensive lifestyle interventions
por: Cathy J. Sun, et al.
Publicado: (2024)

Residual insulin secretion in long‐standing type 1 diabetes
por: Petra Augstein, et al.
Publicado: (2025)

Real‐world glycaemic outcomes of automated insulin delivery in type 1 diabetes: A meta‐analysis
por: Qin Yang, et al.
Publicado: (2024)

Efficacy and safety of oral semaglutide treatment in a Danish type 2 diabetes outpatient clinic: Real‐world evidence
por: Alexandra A. Weinreich, et al.
Publicado: (2025)

Interactive calculator to estimate insulin sensitivity in type 1 diabetes
por: Andrzej S Januszewski, et al.
Publicado: (2024)

Differential associations of risk factors with severe and non‐severe hypoglycaemia: the Hypoglycaemia Assessment Tool prospective observational study in people with insulin‐treated type 1 diabetes and type 2 diabetes
por: Ying He, et al.
Publicado: (2024)

The effect of sugarcane extract supplementation on glycemic control in a mouse model of type 1 diabetes
por: Amgad Zaky, et al.
Publicado: (2025)

Low immunogenicity of insulin efsitora alfa in participants with type 1 and type 2 diabetes mellitus
por: Yun Wang, et al.
Publicado: (2025)

Cholesterol accumulation in monocytes is associated with the severity of diabetic complications and the efficacy of glycemic control interventions in patients with type 2 diabetes
por: Hideyuki Okuma, et al.
Publicado: (2026)

Effects of insulin‐induced hypoglycaemia on cardiac function in people with type 1 and type 2 diabetes and people without diabetes
por: Therese Wilbek Fabricius, et al.
Publicado: (2025)

Economic burden of type 2 diabetes management in France according to clinical characteristics
por: Bruno Guerci, et al.
Publicado: (2026)

Weight loss is associated with improved daytime time in range in adults with prediabetes and non‐insulin‐treated type 2 diabetes undergoing dietary intervention
por: Souptik Barua, et al.
Publicado: (2025)

Dual action of imeglimin on insulin secretion and sensitivity in type 2 diabetes
por: Tsubasa Tajima, et al.
Publicado: (2026)

Faster‐acting insulin aspart versus insulin aspart for adults with type 1 diabetes treated with non‐automated insulin pump and continuous glucose monitoring—A double‐blind randomized controlled crossover trial
por: Ajenthen G. Ranjan, et al.
Publicado: (2025)

Long‐term effects of continuous glucose monitoring on glycaemic control: Real‐world evidence in a general adult population with type 1 diabetes in Norway
por: Bjørn O. Åsvold, et al.
Publicado: (2025)

Validation using item response theory, and assessment of sensitivity to change of the Hypoglycemia Awareness Questionnaire in patients with type 2 diabetes treated with insulin
por: Julieth Patricia García‐Lugo, et al.
Publicado: (2025)

No evidence from euglycaemic–hyperinsulinaemic clamp studies for greater insulin sensitivity in adults with type 1 diabetes using insulin pump versus multiple daily insulin injections—Post hoc meta‐analysis
por: Andrzej S. Januszewski, et al.
Publicado: (2025)

Efficacy and safety of switching to iGlarLixi from premixed insulin therapy in patients with type 2 diabetes: A real‐world experience
por: Chun‐Jui Huang, et al.
Publicado: (2026)

The insulin‐like growth factor system and the progression of renal complications of type 2 diabetes
por: Adrian Heald, et al.
Publicado: (2026)

Clinical evaluation of diabetic neuropathy in adult patients with type 1 diabetes and its possible association with insulin resistance
por: Claudia González-Milán
Publicado: (2017)

Clinical significance of coefficient of variation in continuous glucose monitoring for glycemic management in children and adolescents with type 1 diabetes
por: Tatsuhiko Urakami, et al.
Publicado: (2024)

The impact of handgrip strength and waist circumference on glycemic control: Prospective, observational study using outpatient clinical data in Japanese patients with type 2 diabetes mellitus
por: Shuhei Nakanishi, et al.
Publicado: (2024)

Importance of targeting post‐prandial hyperglycaemia to achieve HbA1c goals in insulin glargine‐treated subphenotypes of type 2 diabetes
por: Wolfgang Landgraf, et al.
Publicado: (2025)

Time in tight range in automated insulin delivery system users: Real‐world data from children and adolescents with type 1 diabetes
por: Claudia Piona, et al.
Publicado: (2024)

Cost‐utility of once‐weekly insulin icodec versus once‐daily basal insulins for type 2 diabetes in China
por: Xichen Tong, et al.
Publicado: (2026)

Major adverse cardiovascular events’ reduction and their association with glucose‐lowering medications and glycemic control among patients with type 2 diabetes: A retrospective cohort study using electronic health records
por: Haowen Hsu, et al.
Publicado: (2024)

Postprandial time in tight range with faster insulin aspart compared with standard insulin aspart in youth with type 1 diabetes using automated insulin delivery
por: Klemen Dovč, et al.
Publicado: (2025)

Impact of social disadvantage on clinical and health care use indicators in adults with type 1 diabetes using insulin pumps in Ontario, Canada
por: Youstina Soliman, et al.
Publicado: (2025)

Cumulative risk of diabetic foot complications in risk groups of type 1 and type 2 diabetes: Real‐world evidence from a 22‐year follow‐up study
por: Abhilasha Akerkar, et al.
Publicado: (2025)

Real‐world evaluation of automated insulin delivery therapy in type 1 diabetes: A multicentre study across regional and metropolitan Queensland, Australia
por: Akash Konantambigi, et al.
Publicado: (2025)

Pharmacokinetic and pharmacodynamic properties of once‐weekly insulin icodec in individuals with type 1 diabetes
por: Ulrike Hövelmann, et al.
Publicado: (2024)